Chemosensitivity Assay: Clinical Trials

1 trial of Chemosensitivity Assay, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Chemosensitivity Assay: new trials by email Literature Review of Chemosensitivity Assay trials Research Report on Chemosensitivity Assay

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Carfilzomib, Chemosensitivity Assay, Dexamethasone - Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
Phase 2TerminatedUniversity of Washington92018-02-082022-05-09

Conditions studied

Multiple Myeloma (1)

Sponsors

University of Washington (1)

Countries

United States (1)

Top investigators

Andrew Cowan (1)

NIH funding

P30CA015704 (1)